The FDA has designated the TTFields delivery system as a humanitarian use device for the treatment of pleural mesothelioma. Patients remain at the heart of the work at Novocure, guiding us forward in our goal to deliver a novel, safe and efficacious cancer therapy that prolongs survival while ...
Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma, non-small cell lung cancer, malignant pleural mesothelioma and pleural mesothelioma. Novocure has several additional ongoing or completed clinical trials exploring the use of Tumor ...
Novocure Presents Interim STELLAR Results at IASLC Suggesting Treatment with Tumor Treating Fields Plus Chemotherapy may Extend Survival of Patients with Mesothelioma One-year survival rates of patients treated with Tumor Treating Fields combined with pemetrexed and cisplatin or carboplatin were more than...
“We look forward to seeing the final results from the STELLAR trial,” said Asaf Danziger, Novocure’s CEO. “The interim data give us hope that TTFields used in combination with standard of care chemotherapies may increase sur...
The most typical cell types for mesothelioma cancer are sarcomatoid and epithelioid. What Is Malignant Pleural Mesothelioma Pleural mesothelioma is the most common type of asbestos-related cancer. Though itâs an aggressive illness, ongoing advancements in chemotherapy, surgery and clinical trials are ...
combination with our work in mesothelioma, it really points to our development of a franchise in this area. The trial is designed to enroll 66 patients. We expect to start soon. And the overall response rate is a well-established surrogate endpoint and overall survival in PFS in Phase 2 ...
85%–95% of all solid pancreatic tumors. As a highly lethal malignancy, it is the seventh leading cause of cancer death worldwide and is responsible for more than 300,000 deaths per year. PDAC is highly resistant to current therapies, affording patients a 5-year overall su...
Most of the small reductions in cancer deaths are due mostly to earlier detection which increases five year survival rates – the yardstick conventional medicine uses to determine success. There is a very good explanation for why cancer research has failed so badly… It has been directed away ...
(SCLC) in approximately 15% of cases. Lung cancer has the highest total incidence of any cancer in China. According to the World Health Organization, the incidence of lung cancer in China in 2020 was 815,563 cases, with 714,699 deaths. In Ch...
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries ...